Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing–Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies
Crossref DOI link: https://doi.org/10.1007/s40120-016-0042-8
Published Online: 2016-03-01
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gold, Ralf
Giovannoni, Gavin
Phillips, J. Theodore
Fox, Robert J.
Zhang, Annie
Marantz, Jing L.
Funding for this research was provided by:
Biogen
